Atticus and FMC Resolve Chlorantraniliprole Litigation With a Settlement

By Atticus|10 October 2025

FMC and Atticus have settled their dispute over Chlorantraniliprole (‘CTPR’), resulting in Atticus’s withdrawal of its declaratory judgment action against FMC. With the settlement, Atticus plans to enter the CTPR market beginning December 7, 2025.

“We are pleased to arrive at this professional and respectful outcome that advances a superior chemistry through its full product life cycle and agronomic potential,” states Randy Canady, CEO, Atticus. “As the price-to-agronomic value of CTPR becomes more aligned, end-users will be empowered to use CTPR in more routine agronomic rotations for better, more cost-effective in sect control.”

Historically, early commitments have led to missed opportunities once all next season’s brand alternatives were introduced. As a result, Atticus launched the initiative to elevate product awareness prior to customers potentially staging inventory that may not prove cost competitive.

The Portfolio Branding Bars below offers a perspective on the comprehensive CTPR portfolio that Atticus deliberately pursued to sit parallel to all CTPR branded offers while positioning Atticus as the one-stop CTPR supplier to accommodate customer preferences.

 

Top Articles
ICSCE 2026 Dubai: Indian Agrochemical Event Highlights Market Trends, Sourcing Opportunities

While the chemistry isn't unique, the Atticus experience is. Atticus is a demand-driven manufacturer of battle-tested chemistries, established in 2014 and built from the ground up with a clear purpose to Enhance Daily Life. Through our Agriculture and EcoCore portfolios, our team is committed to helping
you maximize your input requirements with dependable solutions. See all author stories here.